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The possibility that autoclastic immune reactions are causally involved in 
some human diseases has led to a  search for evidence of immunological phe- 
nomena in the lesions of such diseases. The demonstration, by immunofluores- 
cence, of bound T-globulin (1) was the first, and till recently, almost the only 
technique available for this purpose.  By this method, bound T-globulin has 
been found in the lesions of experimental immune disorders  such as experi- 
mental serum sickness (2) and experimental nephritis (1): and in the lesions of 
human  diseases  such  as  systemic  lupus  erythematosus  (L.E.)  glomerulo- 
nephritis, amyloidosis, and some of the other connective tissue disorders (3-7). 
Attempts have been made to show that such bound T-globulin is likely to be 
antibody by showing its presence independent of other serum proteins such as 
albumin and fibrinogen (8), and by eluting the T-globulin at acid pH (9). 
There remains, however, a  wide gap between the demonstration of bound 
"y-globulin in a lesion and the implication of immune reactions as pathogenic 
factors. It has been widely felt that one step towards closing this gap would be 
the demonstration of complement in the lesions, since it has been found (10) 
that the fixation of complement on tissue cells produces cytotoxic changes. To 
apply these findings to the lesions of disease, it is of course necessary to detect 
the patient's own complement that has been bound in vivo. 
The possibility of demonstrating the patient's own in vivo bound complement 
has recently become feasible following the purification from human serum of 
/3xo-globulin, a moiety of the third component of complement (11).  Since/3m 
is strongly antigenic and is,  in part,  fixed on immune precipitates; and also 
since its fixation is one of the last steps in complement binding, it provides a 
highly suitable antigen for studying complement fixation by immunofluores- 
cence. An immunologicaUy pure anti-/31c serum has been prepared in rabbits, 
a  fluorescein conjugate of which serves as a  specific  reagent for the detection 
of the bound C' component. 
A number of studies have appeared  on the localization of complement, added in 
vitro, to tissue sections. These stem from the work of Goldwasser and Shepard  (12) 
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who were interested in using a single fluorescein conjugate in conjunction with anti- 
bodies from different species. The method was further developed and applied to the 
examination of experimental lesions by Klein and Burkholder (13); and subsequently 
Vogt and Kochem  (14)  have successfully applied it in human  amyloid and  Strauss 
and his colleagues (15) in myasthenia gravis. The principle of the Goldwasser method 
is to fix guinea pig complement onto tissue sections from other species, using standard 
serological controls  to  show  that  the  fixed material is  specifically complement.  A 
ttuorescein-conjugated "anti-guinea pig complement" serum is then used to detect the 
fixed material.  The  exact specificity of  this antiserum is unimportant and  equally 
good results have been obtained (13)  with a crude anti-guinea pig globulin serum as 
with more defined antisera. 
The  demonstration  of  in  vlvo bound  complement represents  a  totally different 
problem. Not only is there no control over the conditions under which the complement 
is fixed, but the complement is of the same species as the rest of the tissue. This leaves 
the precise antigenic specificity of the "anti-complement"  serum as the only factor 
from which the specificity for complement of the staining can be inferred. Although 
attempts to make "anti-complement" sera go back for many years, such sera usually 
contained antibodies against multiple antigens and no firm evidence has been pro- 
duced that they reacted exclusively with complement components. Such reservations 
notwithstanding, evidence has been adduced by the use of anti-complement sera for 
the  presence  of  in  ~i~o bound  complement  in  lupus  nephritis  by  Freedman 
and Markowitz (16), and in experimental nephritis in the rat by Klein and Burkholder 
(13). 
Using a  fluorescein conjugate of an immunologically pure anti-tim globulin 
serum,  the  question  of  the  occurrence  of in  dvo  bound  complement  and  its 
relation to in vitro complement fixation and to the presence of some other serum 
components in lesions has been investigated in a  number  of diseased human 
tissues.  In the present communication the methods and  the initial results are 
presented. 
Materials and Methods 
Preparation of Sections.--Tissues were obtained at postmortem, within 12 hours of death, 
or by biopsy. The tissues were cut into suitable size blocks and either frozen at once in a dry 
ice and acetone mixture, or embedded in gelatin before freezing as described by Burkholder, 
Littell, and Klein (17). In either case the frozen blocks were then stored at --20°C. 
Sections were cut at a thickness of 4 to 6 microns in a Harris International cryostat, de- 
hydrated, first by air-drying and then in a vacuum desiccator for 30 minutes, and then fixed 
in acetone for l0 minutes at 4  °. They were then stained immediately or stored at -20  ° for up 
to 3 days. 
Hematoxylin and eosin-stained preparations were  obtained for all tissues,  either from 
formalin-fixed tissue taken at the same time, or by fixing sections from the cryostat in formalin. 
Where indicated, other histological techniques were also used. 
Antisera.--All  antisera were prepared in rabbits. A predominantly 3"-globulin fraction of 
the sera was prepared by a single precipitation with 15 per cent sodium sulfate. The precipi- 
tated globulins were washed once in 15 per cent sodium sulfate, redissolved in isotonic phos- 
phate buffer, pH 8.0, and then dialyzed against phosphate buffered  saline, pH 7.3  (PBS). LACHMANN, MULLER-EBERIIARD~ KUNKEL~ AND PARONETTO  65 
Conjugation  with  fluorescein isothiocyanate  (Baltimore  Biologicals)  was  carried  out  sub- 
stantially  as described by  Marshall,  Eveland,  and  Smith  (18).  The  conjugates were freed 
from excess fluorescein either by dialysis or by filtration through sephadex (Pharmacia). The 
latter method gives a  very good separation of the conjugate from the free dye and can be 
completed in  a  few hours.  Before use  the conjugates were absorbed  with guinea  pig liver 
powder. 
All globulin solutions were stored at 4 ° with  1/~000 sodium azide. Estimations of protein 
concentration [P] were made by the Folin method. The concentration of fluorescein [F] in  the 
conjugates was measured approximately by their optical density of 495 In# and comparison 
with a  standard curve (12). 
The following conjugates have been used: 
Anti-fllc-Globulin.--The  antiserum was prepared by immunization with pure/31c-globulin 
(prepared as previously described  (11)). The conjugate was used at protein [P]  =  13.6 mg/ml 
and  fluorescein [F]  =  35 #g/ml.  The  fluorescein:protein ratio  [F]/[P]  =  2.6  X  10  -8.  The 
conjugate gave a single characteristic/3tC--fllA line in immunoelectrophoresis (Text-fig. 1). 
Anti-TS  "y-Globulin.--The  antiserum  was  prepared  by  immunization  with  "/-globulin 
aggregates prepared by heating human Cohn fraction II.  The conjugate was used at  [P]  = 
9.6 mg/ml and  [F]  =  25 #g/ml.  [F]/[P]  =  2.6  X  10  -8.  The conjugate gave a  single, char- 
acteristic T-globulin line in immunoelectrophoresis (Text-fig. 2). 
Anti-19S  "y-Globulin.--The  antiserum  was  prepared  by  immunization  with  the isolated 
macroglobulin  from  the  serum  of  a  patient  with  Waldenstr6m's  macroglobulinemia.  The 
conjugate was used at  [P]  =  10.2  mg/ml and  [F]  =  22.5 #g/ml [F]/[P]  =  2.2  X  10  -8. The 
conjugate  gave  a  strong  characteristic  macroglobulin  line  on  immunoelectrophoresis with 
normal serum and a faint anti-7S "),-globulin line (Text-fig. 2). To avoid lowering the antibody 
titer, the antiserum was not absorbed with 7S ")'-globulin, and a blocking technique was used 
on the sections to control specificity. 
in the optical system used these three conjugates gave virtually no background  staining 
and good specific fluorescence. 
Anti-fibrinogen.--The  antiserum was prepared by immunization with commerically avail- 
able fibrinogen (pentex Fr. I). It was absorbed with human serum. The conjugate  was used 
at [P]  ~  25 mg/ml and [F]  =  200 #g/mE  [F]/[P]  =  8.0 X  10  -8. The conjugate gave a  single 
faint line on immunoelectrophoresis (Text-fig.  1).  This conjugate gave a  moderate  degree of 
background staining but its specific fluorescence was very bright. The low antibody activity 
made it necessary to use the serum at the high protein concentration and consequently high 
levels of fluorescence. For our optical system this serum was less satisfactory than the others. 
Optical  System.  A  Leitz  labolux  microscope was  used  with  an  Osram  HBO  200  watt 
mercury lamp, a 4 mm UGI activating filter and a  D  120 A dark-field immersion condenser. 
Microscope slides were of 1 mm thickness. 
Evaluation  of Staining  Reactions.--Staining  was  assessed  subjectively  on  the  following 
graded scale: 
Negative  Feeble 
+ 
Moderate 
+ 
Bright  Very bright 
++  +++ 
Immunofluorescent Staining Methods:- 
To demonstrate file-globulin,  7S T-globulin  or fibrinogen:  One section, three times washed in 
PBS was stained for 30 minutes at room temperature with the conjugate. A  control section 
was incubated similarly with the corresponding unconjugated globulin solution (at a  protein 66  COMPLEMENT  IN  TISSUE  SECTIONS 
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concentration two to three times that of the conjugate) before adding the conjugate, the section 
not being washed between the two incubations. In occasional cases three successive additions 
of unconjugated globulin were made instead of just one before adding the conjugate. A dif- 
ference of two grades or more in the intensity of fluorescence of the two sections was taken to 
indicate "specific staining." 
To demonstrate 19S "y-globulin: To eliminate the reaction with 7S 3'-globulin the test section 
is pretreated  with unconjugated,  anti-TS ")'-globulin before  adding  the  anti-19S  conjugate 
The control section was pretreated in the usual way with unconjugated anti-19S 3'-globulin. 
Indirect Rheumatoid Factor Staining.- 
The test section was treated for 30 minutes at room  temperature with diluted serum  B 
containing a  uniquely high titer of rheumatoid factor or isolated rheumatoid factor.  [t was 
then washed three times in PBS and stained with anti-19S conjugate. The two sections used 
in the detection of  19S above acted as controls for this system. Only if bright 7S ~,-globulin 
staining had  been found was blocking of  the  test  section with unconjugated  7S ~, globulin 
necessary before staining. 
The procedure for the model system in Table II was as follows:  Substrate was treated with 
source of antibody for 30 minutes at room temperature, washed three times, and then treated 
with source of rheumatoid factor for 30 minutes at  room  temperature.  After three  further 
washes the slides were treated for 30 minutes at room temperature with unconjugated anli-7S 
"y-globulin,  and were then stained with the anti-19S conjugate. 
To demonstrate in vitro complement  fixation:  Sections were incubated for 30 minutes at 37 ° 
with a fresh normal human serum known to be free of rheumatoid factor, immunoconglutinio 
and antibodies to human tissue antigens demonstrable by complement fixation or immmm- 
fluorescence. The sections were  then washed three times in PBS  and stained with anti/31c: 
globulin conjugate. In the experiments using reagents for the detection of comlflement corn 
ponents these were prepared by standard methods (19, 20). 
Immunoelectrophoresis.--This was carried out according to Seheidegger (33). 
RESULTS 
To  Show in  a  Model  System  That  the  Fixation  of ~ic  Detected by [mmuno- 
fluorescence  is  Comparable  to  Its  Behavior  in  a  Hemolytic  System.---In  a 
hemolytic  system  (10)  ~1c  represents  the  hydrazine  sensitive  moiety  of  (?':~ 
(the  third  component  of  complement)  and  reacts  with  the  complex  EAC',m 
(antigen-antibody-llS  component-first, fourth,  and  second  complemenl  com- 
ponents).  It  does  not  react  with  EA  (antigen-antibody  complexes)  or  any  of 
EAC ~ complexes formed before EAC'0m.  The fixation of ~1c on EAC',14~ occurs 
best at 37 ° and is inhibited at 4 °. It does not require  Ca or Mg ions. 
For  testing  /3~c  fixation  by  immunofluorescence  the  following  system  was 
employed.  Sections of normal human  liver were treated with a  globulin fraction 
of  a  lupus  serum  containing  high  titer  complement-fixing  antibodies  to  cell 
nuclei.  After  washing,  the  sections  were  treated  with  various  complement 
reagents,  washed,  and then stained with anti  ~c  conjugate.  Table I  shows  the 
results obtained. 
It can be seen that  the results correspond  exactly  to  the  behavior of ~c  in 
the hemolytic system as described above. In the immunofluorescent system the LACItMANN~  M'0LLER-EBERHARD~  KIYNKEL,  AND  PARONETTO  69 
TABLE  I 
A  Model System to Show the Spe~if~ity of the Immu~ofluorescent  Determi~alion  of O~o-Globulin 
Normal liver sections, treated for 30 rain. at 25 ~ with lupus 
globulin (P 10 mg/ml) washed and treated with:-- 
Phosphate  buffered saline 
t~  ~t  ct 
Fresh human serum 
tt  tt  tt 
ct  tt  tt 
Fresh human serum +  0.01 x~ EDTA 
Human serum, heated 56  ° for 30 min. 
g~ls 
R1 
R~ 
1% +  fl~e-globulin 
1%  (standard reagent) 
1% (reabsorbed with excess zymosan) 
Guinea pig 1% 
......  +  flto-globulin 
~tc-globulin 
Normal liver sections  (no antibody added 
washed and treated with :-- 
Fresh human  serum 
30 rain., 37 ° 
cc  tl  Ic 
30 rain., 37 ° 
,,  ,,  , 25 ° 
,,  ,,  40 
30 min.,  37 ° 
t¢  c~  tt 
30 rain., :37  ° 
gl  II  ll 
li  l|  ~¢ 
l~  ll  |I 
ll  g~  II 
tt  tg  tt 
tc  tt  tt 
It  Ig  tt 
It  tg  tt 
tt  cl  tt 
30 min., 37 ° 
ct  ct  cc 
Sections then washed and 
stained for 30 rain. at 25  ° with 
conjugates of :-- 
Anti-7S v-globulin 
Anti-Blc-globulin 
Anti-file-globulin 
tt  ~t  tt 
Anti-fllc-globulin 
c~  ~t  ~t 
Anti-~lc-globulin 
tl  cc 
~c 
tt 
ct 
~t 
ct 
cl 
Nuclear 
fluore- 
$ceuce 
++ 
0 
++ 
+ 
0 
4- 
-4- 
tt  tt  0 
....  ++ 
c~  ~t  0 
tt  ¢t  0 
....  ++ 
tt  c¢  0 
t~  c~  0 
....  +-t- 
tt  tt  0 
Anfi-TS ,r-globulin 
Anti-~lo-globulin 
Smear of heat-aggregated human fraction 
II 7-globulin washed and treated with:--- 
Fresh human  serum  30 rain., 37 °  Anti-~ic-globulin  +++ 
Heated  "  "  "  "  "  "  "  "  0  P 
reagents  are  used  undiluted,  and  those  which  are  more  difficult  to  prepare 
satisfactorily  (Rus and R1) retained  feeble staining  although  they were satis- 
factory for use in hemolytic assays. As file-globulin is itself hydrazine-sensitive 
it  is  necessary  to  add it  to  an R4 before  concluding  that  C',  is  essential  for 
file fixation.  A  hemolytically  inert  C',  retained  bright  staining  which  was, 
however,  removed  by  a  further  absorption  with  zymosan.  Tmmunoelectro- 
phoresis showed that the standard R3 contained a little/~c-globulin,  while the 
reabsorbed  reagent  contained  only the  inactivated  form fl~A-globulin.  An  R3 70  COMPLEMENT  IN  TISSUE SECTIONS 
reagent made from guinea pig serum gave, of course, no staining, but on addi- 
tion of/3~c-globulin bright staining was obtained./~c-globulin on its own gives 
rise to no staining. 
In the absence of antibody, the complement reagents did not  lead  to  /3~c 
fixation on the  liver sections.  Smears of heat-aggregated "/-globulin, on the 
other hand, would act alone as substrate for complement fixation. ~1c, once 
fixed, was not removed by treatment of the section with EDTA, nor by elution 
with pH 3 buffer for 10 minutes at room temperature. 
TABLE  II 
Model system to show the specificity of 'Indirect  Rheumatoid  Factor' staining 
Substrate  Source of antibody  Source of rheumatoid  factor (R.F.)  Staining 
None  Normal liver section 
Normal liver section 
Phosphate buffered 
saline 
c~  cc 
Lupus  globulin  (pa- 
tient)  =  10 mg/ml 
Serum  B,  (high 
titer R.F.) 
Isolated R.F. 
Normal serum 
None 
Smear  of  heat-aggregated 
human  fraction  II  ~- 
globulin 
cc  ~ 
None 
"  Serum B 
"  Isolated R.F. 
"  Normal serum 
None 
Serum B 
Isolated R.F. 
Normal serum 
0 nuclei 
0  " 
0  " 
0  " 
+ 
++ 
++ 
4- 
4- 
nuclei 
smear 
++  " 
++  ,, 
A  similar  model  system was  used  to  show  the  specificity of the  indirect 
rheumatoid  factor  staining  for  antigen-antibody  complexes and  aggregates. 
Table II  shows  the results. 
The Demonstration of in  Vivo Bound file-Globulin in Tissue Sections.--The 
tissues examined for the presence of file-globulin and 7S T-globulin are pre- 
sented in Table III to VI. For convenience the material is presented according 
to diagnosis.  Only specific staining  is recorded. Table III shows  the  results 
obtained with material from cases of systemic lupus erythematosus. Staining 
with anti-fllc conjugate was found predominantly in the glomeruli affected by 
lupus  nephritis  in  which  the  tufts  still  persisted.  Hyalinized  and  fibrosed 
glomeruli showed little staining. The walls of small vessels in the kidney and LAC~MAN'N~ MULLER-EBERHARD~ KUNKEL, AND PARONETTO  71 
TABLE III 
Specific tim-Globulin and 7S y-Globulin Staining in Tissues frora Patients with Systemic Lupus 
Erythematosus 
C 
D 
E 
F 
Tissue 
Kidney 
Lymph node 
Liver 
Spleen 
Liver 
Lymph node 
Spleen 
Heart 
Renal biopsy 
Renal biopsy 
Spleen 
Liver 
Heart 
Kidney 
I Thyroid 
Histological  picture 
Lupus nephritis 
Increased plasma cells 
No lesions 
No lesions 
Increased plasma cells 
Onion  skin  lesions 
(rare) 
No lesions 
Slight interstitial fi- 
brosis;  glomeruli 
not obviously ab- 
normal 
Severe glomerular dis- 
ease 
Anti- 
globulin 
+++ 
+++ 
Features stained  by: 
Anti-TS 
7-globulin 
Glomeruli  + + + 
Occasional vessel  + + + 
0  Casts  + + 
0  Plasma cells  + + 
0  Plasma cells  ++ 
0  0 
+  Vessels  + 
0  Occasional plasma cell  + + 
0  Connective  tissue  in  -4- 
portal tract 
0  Plasma cells  + + 
Chronic vasculitis 
Severe fatty change 
No lesions 
Lupus nephritis 
No lesions 
+ +  Plasma cells  + + 
(many, 
+  Intima of some vessels  + 
+  Amorphous bodies  + 
+ +  Patches of glomerular  + 
basement membrane 
4-  Glomemlar basement  0 
membrane 
4-  Intima of vessel  + 
0  Casts  -4- + 
-4-  Intima of vessels  +'4- 
0  Intracellular granules  ± 
0  0 
-4-+  Patches of glomerular  + 
basement membrane 
+  Occasional vessel  ++ 
0  Casts  + + + 
0  0 
spleen were  also stained.  In these sites tim staining ran generally parallel to 
7-globulin  staining.  In  anatomically  "normal"  parts  of  the  tissue  file  was 
not found. Most renal casts and the great majority of plasma cells did not stain 
with antifl-~c globulin. However,  in a  lupus spleen a  small proportion of the 72  COMPLEMENT  IN TISSUE  SECTIONS 
plasma cells did stain specifically with ~1c antiserum. The term "plasma cell" in 
this connection describes a  cell of regular oval shape, with a  single eccentric 
nucleus and a non-granular cytoplasm. 
TABLE IV 
Olc and 7S staining  in "nephriHs" 
G 
H 
I 
J 
K 
m 
L 
M 
N 
Clinical diagnosis 
Subacute  glomerulo- 
nephritis 
Subacute glomerulo- 
nephritis 
Relapsing glomerulo- 
nephritis  (in  remis- 
sion) 
Hypertension 
Acute nephritis 
Generalized arterio- 
sclerosis 
Polyarteritls nodosa 
Malignant  nephro- 
sclerosis 
Histological picture 
in kidney 
Typical histology 
Membranous glomeru- 
lar lesions 
Some swelling  of  glo- 
meruli 
Arteriosclerosis chronic 
pYelonephritis 
Some swelling of  glo- 
meruli.  Increased 
cellularity  of  tufts 
Chronic pyelonephritis 
Focal glomerular ne- 
crosis 
(No  typical  poly- 
arteritis  lesions  in 
block examined) 
Necrofizing ar  teriolitis 
focal  glomerular  ne- 
crosis 
Features stained  by 
Anti-Sic-  Anti 7S 
globulin  ~'-glohulin 
+~  Glomerular tufts  -{--{-  (basemen1 
membrane) 
~  Afferent  arterioles  -{-~- 
0  Plasma cells  -I-+ 
0  Casts  +++ 
++  Glomeruli  "H--l- 
0  Plasma cells  ~ 
-{-  (rare  Glomemlar tufts  -{-  (throughout~ 
streaks) 
+  Glomerular tuft  -l- 
-{-  Thickened intima of vessels  -{- 
+  (through-  Glomeruli  ++  (through. 
out)  out) 
+  Occasional  small vessel  -t- 
-b  Glomeruli  --{- 
-b  Intima of some vessels  -t- 
0  Casts  +-]-+ 
-~  Occasional  vessel  + 
0  Plasma cells  ++ 
-4-  Streaking  in  glomerular  -~ 
tufts 
+  (patchy)  Glandular tufts  "b+ (through- 
out) 
-{-+  Occasional vessels  -H- 
m 
0  Birth injury  Normal  0  0 
Table IV shows the results on kidney sections from cases of "nephritis"-- 
using this term widely. Bright file-globulin staining was found in the glomeruli 
of the two cases of subacute glomerulonephritis and in one of these cases there 
was some staining of the intima of the afferent arterioles as well. Staining of 
glomeruli in the three cases of acute glomerulonephritis was less strong but the 
material here was in no case obtained at the height of the disease. Some staining 
was found in the glomeruli of the single cases of chronic pyelonephritis, poly- 
arteritis nodosa, and malignant nephrosclerosis. In all these cases, again,  the LACIlM.AIN'N, M'0-LLER-EBERHARD~  KUNKEL~ AND PARONETTO  73 
staining occurred only when there were anatomical lesions and it was more or 
less parallel with the staining of T-globulin. 
Table V shows the results on 3 cases of amyloid that were studied. One was of 
primary type and involved the heart predominantly, another was also regarded 
as primary although  spleen and liver were involved. The  third  case  was  of 
secondary type with the main involvement in kidney and liver. All three cases 
showed bright staining of the amyloid for tim-globulin. In other respects, how- 
ever, there were differences among the amyloid deposits. In one case of the three 
the unstained deposits showed a bluish autofluorescence. In this case and one 
of the other two there was staining with the anti-7S q-globulin serum. In the 
TABLE  V 
flto-Globulin and 7S */-Globulin Staining in Amyloid 
•  ~  Tissue 
P  Spleen 
Liver 
Q  Heart 
R  Renal bi- 
opsy 
Histological  picture 
Well marked amyloid de- 
posits around vessels 
No amyloid deposits 
Amyloid deposits between 
muscle 
Amyloid in glomeruhs in 
walls  of  vessel and 
around tubules 
Features stained by: 
Anti-~lc-  Anti-TS 
globulin  7-giobulin 
++  Amyloid  deposits  ++* 
0  Plasma cells  + + 
0  0 
++  Amyloid  deposits  ++ 
++$  All amyloid deposits  0 
0  Casts  ++ 
* 7S v-globulin is more extensive than fl~c. 
Requires three applications of inhibiting serum to show specificity. 
third case there was no T-globulin staining and it needed three applications of 
unconjugated antiserum to inhibit the anti-tim staining. This was interpreted 
as indicating a high concentration of tim at the binding site. This last case was 
studied  further and is discussed  again below. 
Table  VI  shows  the  results  in  a  miscellany  of  other  pathological 
tissues studied. Most of these show no tim staining. However, positive staining 
was found in the intima of the smaller arteries of several tissues of a patient with 
WaldenstrSm's macroglobulinemia. These vessels were not obviously abnormal 
on conventional histology and did not stain with  anti-7S  ~f-globulin. One  of 
these tissues was studied in greater detail and will be discussed again. 
The  spleen of a  child with idiopathic  thrombocytopenic  purpura  and  he- 
molytic anemia showed staining of the intima of small vessels with both anti- 
file and anti-7ST-globulin. The reticulum around the vessels stained with anti-file 6 
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and with anti-fibrinogen but not with anti-7S3,-globulin. In this spleen a  few 
"plasma cells" were again seen to stain with anfi-/~m. 
The heart of a patient dying of acute rheumatic fever showed staining of the 
intima of vessels in the Aschoff bodies with anti-/~ic.  Many small "droplets" 
stained with both anti-/~m and anti-7S v-globulin. These droplets, which were 
extracellular, were found to stain with the periodic acid-Schiff reagents after 
diastase  treatment and  were  palely eosinophilic and  difficult to  see  on  the 
TABLE  VII 
Further Immunofluorescent  Studies on Sdected Tissues 
R 
T 
SLE 
Diagnosis 
SLE 
WaldenstrSm 
macroglobu- 
linemia 
Amyloidosis 
Allergic angiitis 
SLE  Liver 
Tissue 
Kidney 
Kidney 
Kidney 
Lymph 
node 
Liver 
0  ++  4-  ~  + 
Histological 
feature 
under study 
Glomerular 
tufts 
Plasma cells 
Casts 
Intima  of  ar- 
terioles 
Amyloid 
Reticulum 
Anti-~io  Indirect 
Anti-  (after  Anti-TS  Anti-  rheumatoid 
01o-  incuba- ~,-glob-  19S 
glob-  tion  ulin  factor staining 
ulin  with C') 
+++  +++  +++  +  +++ 
0  0  ++  0  0 
0  +  +++  +++  +++ 
++  ++  o  o 
++  ++  o  ]4- 
0  +++  0*  0 
Epithelitun of  0  q-q-  0  2 
bike ducts 
Granules  in 
liver  cells 
around  fat 
droplets 
Anti-fibrinogen 
-{- (occa- 
sionally) 
0 
0 
:e  ++ 
+  ++ 
++-{-  T-F+ 
++  (also  +-i- 
stains  bile 
thrombi) 
(whole 
sinusoid  net- 
work) 
0 
*  After incubation with C', anti-TS  ~,-globulin  staining  was still  negative. 
hematoxylin and eosin section.  Similar droplets  were  seen in  the septa and 
alveoli of the lungs of the same patient. 
Sections of normal liver, kidney, heart muscle, and skeletal muscle showed 
no staining with anti-tim and anti-TS "y-globulin.  Sections of normal spleen 
showed plasma cells staining with anti-7S T-globulin, but no cells staining with 
anti-~m. 
More Detailed Study of Selected Tissues.--Many of the sections were studied 
by further staining techniques. Table VII summarizes some selected results 
that bear upon the significance of the tim staining. In a  typical case of lupus 
nephritis  (A)  the glomeruli stained with anti-/3m- and anti-7S 3"-globulin and 
to a lesser extent with anti-19S 3,-globulin and anti-fibrinogen. Incubation with 76  COMPLEMENT IN TISSUE  SECTIONS 
fresh human  serum  did not  alter  the/3m staining.  The indirect rheumatoid 
factor  staining  was  strongly  positive. 
Lack  of  correlation  between  /3m- and  "},-globulin staining  was  found  in 
renal casts and plasma cells in which staining was obtained only with anti-7- 
globulin. The plasma cells did not stain with tim after incubation with human 
complement nor by the indirect rheumatoid factor method.  The renal  casts 
on the  other hand  stained  with tim',  though by no means  always brightly, 
after incubation with human C'. They, therefore, show some in vitro  comple- 
ment fixation without having complement bound on them in vivo. They stained 
brightly with the anti-19S serum, so that the rheumatoid factor staining  by 
this technique could not be applied. 
Lack of correlation between tim- and 7S ~'-globulin staining was also found 
in the intimal vessel staining found in most of the organs studied of a case of 
Waldenstr~Jm's macroglobulinemia and in the amyloid deposits of one of the 
cases of amyloid. In both of these instances, there was a correlation of stain- 
ing with anti-fibrinogen. However, in many other instances, there was bright 
anti-fibrin staining with no file staining.  In both the instances quoted  there 
was only feeble staining by the indirect rheumatoid factor method. 
Three cases  are  shown  where tim staining  became positive  only after  in- 
cubation with human  C',  i.e.  where there was  in  vitro  but not in  vivo  com- 
plement fixation. The most dramatic example was with a lymph node biopsy 
from a patient (T) with a  tentative diagnosis of allergic angiitis.  This lymph 
node showed no staining with either/~m- or 7S T-globulin. However, its whole 
"reticulum framework"  stained  very brightly  with  anti-/~m,  but  not  at  all 
with anti-TS "y-globulin,  after incubation with  C'.  A  similar pattern of fluo- 
rescence was  found when this node was  stained  by the indirect rheumatoid 
factor method. With anti-fibrinogen more extensive staining of the structural 
background of the gland was  seen.  A  similar spectrum of staining  was  seen 
with the splenic reticulum of a  case of idopathic thrombocytopenic purpura 
and hemolytic anemia in a child (See Table VI). 
The  epithelium  of  the  bile  ducts  in  a  case  of systemic  L.E.  and  some 
granules in the hepatic ceils  of another case also showed solely in  vitro  com- 
plement staining.  The former stained well by the indirect rheumatoid  factor 
method;  the  latter  only feebly. The former failed  to  stain  with  the  anti-T- 
globulin serum; the latter stained feebly. 
DISCUSSION 
From the evidence of the in vitro complement fixation studies it can be in- 
ferred that tim-globulin is fixed on tissue sections under conditions that ac- 
curately parallel those of complement fixation and that in sections, just as in 
a  hemolytic system, it  is  the  SAC'0m  complex with which it combines.  On LACHM.A!WN,  ~LLER-EBERIIARD, KUNK~L, AND PARONETTO  77 
the basis of these findings, it seems highly likely that the demonstration of 
~81o-globulin in an untreated tissue section is indicative of in eivo complement 
fixation at that site. 
From  the initial  survey of pathological material  that  has  been reported, 
there seems to be no doubt  that in  vivo  complement fixation does occur at 
the site of certain lesions and not in normal  tissues.  Furthermore,  analogy 
with the work of Ross and Lepow (10) on the fixation of complement on anti- 
body-sensitized tissue culture ceils would suggest that such complement fixa- 
tion represents a  true biological complement fixation with cytotoxic sequelae. 
However, the exact significance that can be attached to finding complement 
bound  in  a  tissue  requires  continued cautious  evaluation.  Previous  studies 
have tended to assume that even i~ eitro  complement binding could be used 
as  evidence for the presence  of antigen-antibody complexes at  the  binding 
site. In view of the powerful binding of complement to T-globulin aggregates 
(21-23),  whether these be made by heating (24),  treatment with mercapto- 
ethanol-urea (25),  or with bis-diazobenzidine (23),  this assumption is dearly 
unwarranted.  Smears  of  heat-aggregated T-globulin  have  served  as  a  sub- 
strate to show complement fixation by staining with anti-fllc conjugate and 
very bright fluorescence was obtained.  In fact, the presence  of bound com- 
plement at a tissue site can be attributed to any of three situations which are 
known to fix complement: 
(a)  Antibody bound to antigens normally present at the site.  This is the 
situation studied by Ross and Lepow  (10). 
(b)  Antigen-antibody  complexes  unrelated  to  the  tissue  site  and  either 
bound  there  by  immune  adherence  (26)  or  trapped  mechanically.  This  is 
apparently the situation in serum sickness. 
(c) "},-globulin aggregates bound at the site by one mechanism or another. 
Further,  it appears  possible that complement may be bound at the sites of 
immune reactions other than those involving circulating antibodies. 
In experimental conditions, immune complexes can be distinguished from 
T-globulin aggregates by identifying the antigen at the site of the lesion (2); 
but  in  human disease where  the  antigen is  either normally present  at  the 
lesion site or is unknown, this approach  is difficult. 
In view of the finding of file staining at sites showing no ~,-globulin  staining, 
the question arises whether in these cases complement is fixed on a  substrate 
other  than "r-globulin, or whether ,r-globulin is  present  and  is  not stained 
either because there is too little or because it has lost its antigenicity. Com- 
plement is known to be bound on inert particles such as quartz and kaolin, 
and on non-immune precipitates such as those made with DNA and histone. 
Since complement preparations free of T-globulin are not available it is not 
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this is the case, however, is suggested by the observation that such systems, 
after treatment with a heated serum, are agglutinated by an anti--~-globulin 
serum (27). 
A  further reason for believing that ~,-globulin  was present at sites where 
/3m was fixed is based on the reaction with rheumatoid factor. The specificity 
of  rheumatoid  factor  for  aggregated "y-globulin  and  antigen-antibody com- 
plexes is well established (25,  28) and a  reaction with rheumatoid factor can 
be interpreted as showing the presence of 7S ~,-globulin,  either aggregated or 
in an immune complex,  at the reaction site.  An immunofluorescent method 
for this purpose was used on much of the material in this study and showed 
that in all cases where there was/31c bound in vivo, or where it could be bound 
in vitro, there was at least some reaction with rheumatoid factor. The method 
shows promise as an alternative to in vitro  complement staining for showing 
antigen-antibody complexes and aggregated ~,-globulin. 
In vivo it may well be less important from the standpoint of pathogenicity 
whether complement is fixed on one substrate  or another.  Recent evidence 
clearly indicates that "It-globulin aggregates are biologically active in producing 
skin reactions  (21,  29).  An important factor appears  to be whether the site 
of complement fixation is  near  enough a  cell surface for pharmacologically 
active agents to be released. Consequently,/3m fixation in vitro in the absence 
of in vivo binding  could be without cytotoxic importance as would ~lc-binding 
away from cells. 
From  the  material  studied  the  following tentative  conclusions  could  be 
reached.  The  glomerular and vascular lesions of systemic L.E.  and of "ne- 
phritis"  showed in vivo complement binding parallel in distribution with ~,- 
globulin binding, although the relative brightness of the staining with the two 
reagents varied markedly from case to case. Indirect rheumatoid factor staining 
also followed the same pattern of distribution. In these diseases immune com- 
plexes may reasonably be implicated and the complement binding may well 
be producing a  cytotoxic effect. The finding of in vivo bound complement in 
the lesions of systemic L.E. and "nephritis" is also consistent with the idea 
that in  vivo  complement binding is a  factor involved in producing  the low 
serum complement levels often found during the active stage of these diseases 
(30, 31). 
In contrast, the great majority of plasma cells found in the tissues stained 
only with anti-7S v-globulin or anti-19S ~,-globulin and thus seem to contain 
unaggregated ~,-globulin. However, in two tissues a  few cells not readily dis- 
tinguishable from plasma cells,  stained with anfi-/31c. In both cases  this was 
found in the spleen and in conditions (systemic L.E. and idiopathic thrombo- 
cytopenic purpura with hemolytic anemia) where a high level of complement 
production could reasonably be  expected.  It  seems  possible  that  these  cells 
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Thorbecke, and Asofsky (32)  who have shown by a  combination of immuno- 
electrophoreasis  and  amino  acid  incorporation  studies  that  31c-globuiin  is 
formed in spleen and bone marrow. 
The renal  casts  represent  structures  that  are  presumably not  of immune 
origin. They showed staining with anti-7S v-globulin and anti-19S as well as 
by the indirect rheumatoid factor method. Untreated they did not stain with 
anti-~lc; after incubation with complement they did so to a  variable degree. 
It would  therefore appear  that  they contain  some "r-globulin in  aggregated 
form. However, since complement binding was shown only in vitro, this could 
not be implicated in any tubule damage. 
In amyloid the picture was not uniform. In one case there was 31o and no 
"r-globulin  demonstrable  and  the  indirect  rheumatoid  factor  staining  was 
weak. However, in the other two cases 31c- and T-globulin staining was paral- 
lel. In all three cases the 31c was fixed in vivo so that it may have played some 
part in the disease. 
In a number of individuals with miscellaneous conditions, results have been 
obtained  whose  relevance  to  the  diseases  concerned  remains  incomplete. 
However, it is of interest that four lesions in this limited survey stained with 
anti-31c after incubation with serum but not before. It is thus clear that in 
vivo fixation of C' and the ability to fix C' in vitro cannot be regarded as equiv- 
alent. 
Why lesions that fix C' in vitro do not do so in vivo is puzzling and a number 
of possibilities may be considered. It may be that in these cases the C' fixation 
is an artefact; the treatment of the tissue during freezing and fixation producing 
the C' binding sites in certain circumstances perhaps in the presence of large 
amounts  of "r-globulin. However, it was  not possible  to produce C' binding 
in vitro by freezing and thawing tissue in the presence of "r-globulin. A further 
cause  of artefact  could  conceivably be  the  presence  of unsuspected  tissue- 
reactive  antibodies  in  the  C'  source.  This  probably  can  be  excluded since 
anti-7S "r-globulin failed to stain, for example, the lymph node reticulum (T) 
after incubation with  C'.  The possibility that  complement was  in fact fixed 
in vivo,  but  that  the 31c-globulin had lost its antigenic determinants,  could 
not be ruled out but it is difficult to see why, even in this case, the binding 
site should fail to fix 31c in vivo when it can still do so in vitro.  Probably an 
explanation  of  this  effect must  await  more  detailed  information as  to  the 
conditions governing the in vivo fixation of complement. The reverse question-- 
whether  all  sites  that  bind  complement in  vivo  will  also  fix complement in 
vitro--has not so far been investigated. 
It can be concluded that  the detection of in vivo bound complement pro- 
rides a further parameter by which the nature of lesions can be studied and 
that its spectrum is not identical with that provided by the detection of "r- 
globulin or by in vitro  complement fixation. It seems likely that  the in vivo 80  COM]?LEMENT IN TISSUE SECTIONS 
complement binding  reflects processes  at  the  binding  site  that,  at  least  in 
part, are involved in the origin of the lesions there, and thus implicates some 
immune mechanism in their pathogenesis. 
SITMMARY 
A  technique has been described for the demonstration of a human  com- 
plement component by an immunofluorescent method. The component de- 
tected is ~ic-globulin, a moiety of the third  complement component, which 
has previously been obtained in pure form and to which a specific  antiserum 
has been prepared. 
It has been shown in a  model system that the binding of tim-globulin as 
shown by immunofluorescence is  strictly equivalent to  complement fixation 
as assessed by standard serological  methods. 
This  technique has been applied  to  the  detection of in  vivo  bound com- 
plement in pathological human tissues. It was found that in ~vo complement 
binding occurs in the lesions of several human diseases, but not elsewhere in 
the same tissues. In a rather limited survey of diseases that has been carried 
out,  in  e/w  complement binding  was  found particularly  in  systemic L.E., 
various nephritides, and amyloidosis, as well as in single cases of some other 
diseases. 
The spectrum of in ~vo complement binding has been compared with that 
of ~/-globulin  binding  (7S and  19S  types)  and with the demonstration of in 
~tro  complement  fixation  and  rheumatoid  factor  fixation.  It  was  distinct 
from each  of these.  Rheumatoid factor fixation, detected by anti-19S  anti- 
serum  showed promise  as  a  method for  the  detection  of  antigen-antibody 
complexes and aggregated y-globulin in tissue sections. 
The interpretation of these findings in regard to the nature of the binding 
sites, and their possible significance in regard to pathogenic mechanisms have 
been discussed. 
The authors are greatly indebted to  Dr.  C.  K.  Osterland for performing  many of  the 
biopsies; and to Miss M. A. Calcott for technical assistance. 
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EXPLANATION OF PLATES 
PLATE  8 
FIG. 1.  Olomeruli, lupus nephritis (patient A) stained with anti-fllc.  X  100. 
FIG. 2.  Glomerular  tuft, lupus nephritis (patient A) stained with anti-file  and at 
magnification 450 to show the basement membrane localization of the staining. THE ~'OURNAL OF EXPERI]~IENTAL MEDICINE VOL. 115  PLATE  8 
(Lachmann et al.:  Complement in tissue sections) PLATE  9 
Fro. 3.  Glomerular tuft, lupus nephritis  (patient A)  stained with anti-/$~e and at 
magnification 900  to show the basement membrane localization of the staining. THE JOURNAL OF EXPERIMENTAL  MEDICINE VOL. 11.~  PLATE  9 
(Lachmann et al.: Complement in tissue sections) PLATE 10 
FIG. 4.  Glomerulus and small vessel, malignant nephrosclerosis (patient N) stained 
with anti45~c.  X  200. 
FIG. 5.  Amyloid deposits in the spleen  (patient P) stained with anti-~31c X  200. THE JOURNAL OF EXPERIMENTAL MEDICINE  VOL. 115  PLATE  10 
(Lachmann eta/.:  Complement in tissue sections) PLATE 11 
FIG.  6.  Lymph  node,  allergic angiitis  (patient  T)  stained  witl~  anti-3~c  after 
incubation with C t to show reticulum staining.  X  450. 
FIo.  7.  Lymph node, allergic angiitis (patient T)  stained by indirect rheumatoid 
actor method to show reticulum staining.  X  450. TIlE ~OURNAL OF EXPERIMENTAL MEDICINE  VOL.  115  PLATE 11 
(Lachmann et al.: Complement in tissue sections) 